Dermapharm Holding SE (DMPHF)

PNK: DMPHF · Real-Time Price · USD

39.56

0.00 (0.00%)

At close: Apr 25, 2025, 9:30 AM

Dermapharm SE Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	121.19M	158.72M	149.92M	160.32M	120.62M	114.98M	212.81M	6.29M	3.82M
Short-Term Investments	511K	818K	11.44M	11.74M	1.04M	1.06M	1.1M	400K	30K
Long-Term Investments	82.28M	75.34M	65.41M	94.15M	60.08M	63.01M	6.77M	7.72M	14.08M
Other Long-Term Assets	510K	103.93M	1K	11.74M	1.04M	1K	1.1M	800K	60K
Receivables	105M	95.41M	96.72M	72.52M	55.52M	48.88M	34.12M	104.76M	26.3M
Inventory	339.86M	317.41M	251.82M	240.53M	203.26M	172.17M	115.56M	81.11M	84.58M
Other Current Assets	15.73M	46.85M	22.02M	26.74M	12.53M	10.67M	38.18M	78.73M	40.88M
Total Current Assets	593.5M	630.5M	533.95M	519.22M	400.05M	352.94M	371.24M	192.87M	156.96M
Property-Plant & Equipment	315.03M	330.77M	225.67M	222.29M	199.62M	132.59M	80.87M	56.04M	53.36M
Goodwill & Intangibles	1.09B	1.02B	576.36M	559.57M	563.61M	495.27M	244.56M	157.99M	87.06M
Total Long-Term Assets	1.49B	1.53B	878.89M	887.75M	824.35M	691.93M	333.34M	222.43M	154.74M
Total Assets	2.08B	2.16B	1.41B	1.41B	1.22B	1.04B	704.58M	415.3M	311.7M
Account Payables	94.78M	86.64M	56.1M	52.1M	50.37M	35.35M	28.18M	23.37M	24.53M
Deferred Revenue	n/a	942K	155.34M	96.61M	54.78M	50.26M	45.27M	24.2M	24.39M
Short-Term Debt	84.81M	111.43M	1.87M	2.38M	22.2M	8.21M	71.42M	32.13M	68.91M
Other Current Liabilities	74.52M	95.92M	-53.05M	-43.85M	-37.15M	-28.27M	-18.86M	7.51M	6.12M
Total Current Liabilities	326.92M	394.49M	217.79M	155.61M	132.87M	102.42M	146.4M	80.58M	115.42M
Long-Term Debt	877.33M	950.71M	501.84M	565.71M	570.48M	533.59M	232.55M	222.35M	96.75M
Other Long-Term Liabilities	132.09M	268.32M	150.99M	176.8M	186.18M	38.95M	10.78M	38.56M	38.57M
Total Long-Term Liabilities	1.14B	1.23B	662.55M	751.52M	766.94M	657.96M	302.1M	261.04M	135.47M
Total Liabilities	1.47B	1.62B	880.34M	907.13M	899.81M	760.38M	448.5M	341.62M	250.89M
Total Debt	979.61M	1.08B	516.45M	580.3M	606.8M	554.61M	304.32M	254.75M	162.78M
Common Stock	53.84M	53.84M	53.84M	53.84M	53.84M	53.84M	53.84M	120K	1.34M
Retained Earnings	433.19M	367.22M	355.36M	337.95M	177.08M	139.07M	100.99M	25.67M	56.27M
Comprehensive Income	n/a	118.14M	21.61M	4.73M	-9.75M	-7.01M	n/a	n/a	n/a
Shareholders Equity	604.42M	539.21M	531.59M	497.32M	321.97M	278.65M	252.45M	73.69M	56.91M
Total Investments	82.8M	75.34M	76.85M	105.89M	61.12M	64.07M	7.87M	8.12M	14.11M